Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Sun Pharma Advanced Research Company Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn

Sun Pharma Advanced Research Company Ltd: The quarter ending Jun 2026 recorded a net loss of ₹21 crore; the loss narrowed from ₹52 crore in Jun 2025. Sales rose 300.0% to ₹40 crore against Jun 2025. Operating margin rose from -520.0% to -85.0% (435.0 percentage points higher). A reported annual profit of ₹1,552 crore coincided with an operating cash outflow of ₹239 crore in the year ending Mar 2026; the cash-flow reconciliation is important context for the earnings.

Calculated from the stored statements below · Reporting periods remain separate
COMPANY FINANCIAL DATA

Market snapshot

Stored figures, not live quotes. Price record: 14 October 2026, 7:29 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price192₹ per share
Reported P/E3.91Times
Book value per share41.1₹ per share
Reported ROCE165 %Reported return

Stored market and accounting figures

Price record: 14 October 2026, 7:29 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap6,236 Cr.
Current Price192
High / Low289/108
Stock P/E3.91
Book Value41.1
Dividend Yield0.00 %
ROCE165 %
ROE281 %
Face Value1.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

DAILY STORED OBSERVATIONS

Share price history

₹ per share

Last stored price for each available date, not a live quote or an official closing-price series. Missing dates are not filled. Verify corporate-action adjustments against the source.

Chart loads as you scroll.

EARNINGS

Quarterly performance

Jun 2026

The quarter ending Jun 2026 recorded a net loss of ₹21 crore; the loss narrowed from ₹52 crore in Jun 2025. Sales rose 300.0% to ₹40 crore against Jun 2025. Operating margin rose from -520.0% to -85.0% (435.0 percentage points higher). More operating profit was retained from each rupee of sales; check whether that improvement holds across other reporting periods. Prior-year profit was zero or negative; a conventional percentage growth comparison would be misleading.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Quarterly statementAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 242114171713152710881,85340
Expenses 12611311612411211789816274658074
Operating Profit -102-91-103-108-95-104-74-54-52-66-571,773-34
OPM % -427%-432%-740%-649%-566%-808%-499%-198%-543%-838%-673%96%-86%
Other Income 10864200090-12224
Interest 00011135689128
Depreciation 3333333333322
Profit before tax -95-86-100-107-97-108-80-61-52-76-811,761-21
Tax % 0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Profit -95-86-100-107-97-108-80-61-52-76-811,761-21
EPS in Rs -2.94-2.66-3.07-3.29-2.98-3.32-2.46-1.88-1.60-2.34-2.4854.26-0.65

Last Updated: September 29, 2026, 5:26 pm

EARNINGS

Annual performance

Mar 2026

Earnings returned to a reported profit of ₹1,552 crore in the year ending Mar 2026, compared with a loss of ₹345 crore in Mar 2025. Sales rose 2,509.7% to ₹1,879 crore against Mar 2025. Operating margin rose from -454.2% to 85.0% (539.2 percentage points higher). More operating profit was retained from each rupee of sales; check whether that improvement holds across other reporting periods. Prior-year profit was zero or negative; a conventional percentage growth comparison would be misleading.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
PER-SHARE EARNINGS

Earnings per share

Reported annual earnings per share use ₹ per share, while the earnings charts use ₹ crore. Changes in share count and corporate actions can affect the comparison between years.

Earnings per share

₹ per share

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Annual statementAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 14, 2026, 7:29 pm

MetricMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 156161181781837725313723976721,8791,909
Expenses 191224304321334387388324453479399281294
Operating Profit -35-63-123-243-151-310-135-187-214-404-3271,5981,616
OPM % -23%-39%-68%-310%-83%-404%-53%-136%-90%-534%-456%85%85%
Other Income 33145414105711292-213
Interest 02200311138293436
Depreciation 78888911101212111010
Profit before tax -40-70-119-197-145-312-151-203-223-388-3451,5521,583
Tax % 0%0%0%0%0%0%0%0%0%0%0%0%
Net Profit -40-70-119-197-145-312-151-203-223-388-3451,5521,583
EPS in Rs -1.60-2.83-4.82-7.85-5.55-11.92-5.77-7.48-6.86-11.96-10.6447.8348.79
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%0%
Year-on-year profit growth table

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)-75.00%-70.00%-65.55%26.40%-115.17%51.60%-34.44%-9.85%-73.99%11.08%549.86%
Change in YoY Net Profit Growth (%)0.00%5.00%4.45%91.94%-141.57%166.77%-86.04%24.58%-64.14%85.07%538.77%

Growth

Compounded Sales Growth
10 Years:-7%
5 Years:-1%
3 Years:-19%
TTM:-6%
Compounded Profit Growth
10 Years:Not available
5 Years:-2%
3 Years:-30%
TTM:23%
Stock Price CAGR
10 Years:-9%
5 Years:-4%
3 Years:-14%
1 Year:-36%
Return on Equity
10 Years:Not available
5 Years:Not available
3 Years:Not available
Last Year:Not available

Last Updated: September 5, 2025, 1:36 pm

CASH & FUNDING

Balance sheet

Mar 2026

Reported borrowings stood at ₹559 crore in Mar 2026. They increased from ₹265 crore in Mar 2025 (110.9% higher). Read the borrowing notes, repayment schedule and cash-flow statement together; the borrowing balance alone does not establish liquidity or repayment capacity.

Reserves & borrowings

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Balance-sheet statementAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: September 27, 2026, 9:45 pm

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 242425252626262732323232
Reserves 768133160270-45-194448092-2531,301
Borrowings 45632267236791656265559
Other Liabilities 3975111122101224162170302305284275
Total Liabilities 1431632733093982732302808304863292,168
Fixed Assets 677069525810491921061039585
CWIP 0113243252627445472
Investments 00101082118612291200
Other Assets 76921921461061281271504063381792,011
Total Assets 1431632733093982732302808304863292,168
CASH & FUNDING

Cash generation

Mar 2026

Operating activities used ₹239 crore in Mar 2026. Reported free cash flow for the same period was −₹262 crore. Negative operating cash flow means cash left the operating cycle; examine receivables, working capital and the reconciliation in the company filing before attributing a cause. Operating cash flow was negative in each of the last 5 consecutive stored annual periods. A reported annual profit of ₹1,552 crore coincided with an operating cash outflow of ₹239 crore in the year ending Mar 2026; the cash-flow reconciliation is important context for the earnings.

Operating & free cash flow

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Cash-flow statementAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + -41-44-128-183-172-211-152-208-69-429-362-239
Cash from Investing Activity + 53-13-7-105-1021552-29-548391158-24
Cash from Financing Activity + -1511942242745515922961743201262
Net Cash Flow 11-760-63009-8-14-4-1
Free Cash Flow -49-56-136-200-184-264-153-233-84-455-372-262
CFO/OP 110%48%88%71%111%65%111%114%35%105%114%-17%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow-49.00-56.00-136.00-200.00-184.00-264.00-153.00-233.00-84.00-455.00-372.00-262.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

OPERATING CYCLE

Capital efficiency

Mar 2025

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Working-capital days were -1,778 in Mar 2025. That is 1,032 days lower than the same annual period a year earlier. Compare collection, inventory and payment cycles within this feed to understand the movement; these measures do not identify the cause by themselves.

Working capital

Days

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
CAPITAL RETURNS

Returns on capital & equity

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Returns on capital & equity

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Efficiency tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 614721788220762574507582
Inventory Days 00000000
Days Payable
Cash Conversion Cycle 614721788220762574507582
Working Capital Days 12720-161-60-232-98-842-268-301-193-746-1,778
ROCE %21%-32%-71%-94%-143%-62%-183%-242%-218%-67%-109%-298%
SHAREHOLDERS

Ownership trends

Jun 2026

Promoters held 65.68% in Jun 2026. Their share was 0.01 percentage points higher than in Jun 2025. Ownership percentages can change through share issuance as well as transactions. Check exchange disclosures for the explanation and any pledging; the percentage alone is not evidence of investor conviction. FIIs held 3.90% in Jun 2026, 2.43 percentage points above their holding in Jun 2025. DIIs held 0.09% in Jun 2026, 0.88 percentage points below their holding in Jun 2025.

Shareholding comparison

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
SHAREHOLDER PARTICIPATION

Shareholder count

Shareholder count

Shareholders

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Ownership tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 65.68%65.68%65.68%65.68%65.68%65.68%65.68%65.67%65.67%65.67%65.67%65.68%
FIIs 3.67%3.30%3.24%2.64%2.15%2.23%1.45%1.47%1.76%2.04%2.04%3.90%
DIIs 0.65%0.67%0.67%0.17%0.21%0.64%1.13%0.97%1.05%0.78%0.88%0.09%
Public 29.99%30.36%30.41%31.51%31.96%31.47%31.76%31.88%31.52%31.51%31.41%30.34%
No. of Shareholders 1,01,4331,03,9901,02,7431,25,1841,28,2051,31,0341,42,8641,40,7241,36,9971,44,8101,40,6251,41,957
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund 1,767,774 0.38 25.292,413,3082026-06-09 16:02:10-26.75%
ALTERNATE FEED

Financial ratios

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Each card groups related ratios with the same unit. Reporting dates remain visible for every measure; the original ratio table follows the charts.

ALTERNATE RATIO FEED

Profitability ratios

%

Profitability ratios

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Liquidity ratios

Multiple (×)

Liquidity ratios

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Interest coverage

Multiple (×)

Interest coverage

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Valuation multiples

Multiple (×)

Valuation multiples

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting ratio tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23
FaceValue 1.001.001.00
Basic EPS (Rs.) -10.55-11.93-7.82
Diluted EPS (Rs.) -10.55-11.93-7.82
Cash EPS (Rs.) -10.17-11.55-6.50
Book Value[Excl.RevalReserv]/Share (Rs.) -6.683.8815.80
Book Value[Incl.RevalReserv]/Share (Rs.) -6.683.8815.80
Revenue From Operations / Share (Rs.) 2.212.337.36
PBDIT / Share (Rs.) -9.90-11.48-6.26
PBIT / Share (Rs.) -10.28-11.87-6.62
PBT / Share (Rs.) -10.56-11.92-6.86
Net Profit / Share (Rs.) -10.55-11.93-6.86
NP After MI And SOA / Share (Rs.) -10.55-11.93-6.86
PBDIT Margin (%) -447.77-493.24-85.09
PBIT Margin (%) -465.04-509.80-90.01
PBT Margin (%) -477.63-512.05-93.21
Net Profit Margin (%) -477.25-512.55-93.21
NP After MI And SOA Margin (%) -477.25-512.55-93.21
Return on Networth / Equity (%) 0.00-307.91-43.40
Return on Capital Employeed (%) 862.23-154.06-33.00
Return On Assets (%) -102.07-75.18-26.81
Long Term Debt / Equity (X) -0.460.000.00
Total Debt / Equity (X) -1.190.370.00
Asset Turnover Ratio (%) 0.160.110.00
Current Ratio (X) 0.071.022.54
Quick Ratio (X) 0.071.022.54
Interest Coverage Ratio (X) -35.55-219.89-26.61
Interest Coverage Ratio (Post Tax) (X) -36.89-227.50-28.15
Enterprise Value (Cr.) 5059.2711897.665712.17
EV / Net Operating Revenue (X) 70.50157.4923.92
EV / EBITDA (X) -15.74-31.93-28.11
MarketCap / Net Operating Revenue (X) 66.93158.9224.39
Price / BV (X) -22.1495.4711.36
Price / Net Operating Revenue (X) 66.93158.9324.39
EarningsYield -0.07-0.03-0.03

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Sun Pharma Advanced Research Company Ltd 6,236 Cr. 192 289/1083.91 41.10.00 %165 %281 % 1.00
Dredging Corporation of India Ltd 2,560 Cr. 914 1,286/53865.1 4440.00 %4.28 %0.39 % 10.0
Logica Infoway Ltd 317 Cr. 178 244/13922.3 57.40.00 %13.8 %14.9 % 10.0
MPIL Corporation Ltd 27.8 Cr. 487 639/325 1790.00 %21.6 %28.2 % 10.0
Mipco Seamless Rings (Gujarat) Ltd 13.7 Cr. 38.2 44.3/20.554.8 8.930.00 %37.0 %Not available 10.0
Industry Average2,774.13 Cr246.3371.20105.180.04%31.90%48.06%9.00

All Competitor Stocks of Sun Pharma Advanced Research Company Ltd

Explore Industry-wise Company financial data